Women Healthcare Market 2017 to demonstrate progress at a CAGR of 5.04% by 2023

Women Healthcare Market

Acknowledging its growing popularity and the market growth, Market Research Future, recently published a study report – The Global Women Healthcare Market.  Which indicates that the Market is booming and estimated to gain further prominence over the forecast period.  Further MRFR asserts that the Market will demonstrate a massive growth by 2023, phenomenally superseding its previous growth records in terms of value with a whooping CAGR during the anticipated period (2017 – 2023).

Market Research Future published new report, titled “Women Healthcare Market – Research Report: World Forecast to 2023”.

Global Women Healthcare Market – Overview

Healthcare refers to the maintaining or improving health via the prevention, diagnosis etc. in human beings. Woman healthcare is an important branch of healthcare which looks into the diagnosis, treatment and prevention of health disorders related to women including physical & mental wellbeing. Health conditions like menopause, ovarian and cervical cancer, and pregnancy which are unique to women are largely covered. Despite its importance in the healthcare sector, women healthcare is very often an ignored branch in terms of R&D and investor interest.

According to a report published by Market Research Future, the market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023. Despite the fallbacks, the sector is still poised to grow, even pharmaceutical companies are expected to benefit from this growth boom in the sector.

Women healthcare is gaining traction in the healthcare domain due to endorsements from prominent figures and women themselves who have started seeking proper medical treatment and guidance for their issues rather than not treating these issues. This paradigm shift has been bought about by the change in the socio economic status of women in the society who are no longer reliant in others to help them seek medical care. Coupled with government initiatives and interest from multinational pharmaceutical firms, the sector is expected to perform tremendously well in the coming years.

Rise in the number of treatment available for women related diseases and increasing number of advanced technical equipment and therapeutics for gynecological disorders are major factors growing this market worldwide. Factors that are reducing the pace of growth are significant gender-based health disparity, limited awareness about health issues and relatively less income levels in many developing countries have created a significant number of barriers to proper distribution of woman healthcare.

Latest Industry News:

12th October, 2017 Lupin Ltd.’s U.S. arm has acquired the privately held company Symbiomix Therepeutics LLC. For $150 million cash as the drugmaker looks forward to solidifying its presence in the women’s healthcare segment. This deal will help Lupin to build a franchise around women’s healthcare.

7 th November, 2017 Progenity which focuses on women’s health, prenatal screening tests, and oncological risk assessments has raised Raises $125M in Series B Financing. The investment is expected to be utilized in enhancing their company’s offering to its physician clients in the women’s health space countrywide

9th May, 2017 Torrent Pharma has acquired women healthcare brands Regestrone and Pregachieve for India from Swiss pharma major Novartis AG.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3121 .

Global Women Healthcare Market – Competitive Analysis

With the entry of new industry players in the global woman healthcare market segment, a trend of solid, volume-driven growth has been observed in the market with the addition of new and advanced product types & procedures in the segment. Companies are aiming to capture & solidify their share of the market segment, by competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies. Constant improvements in R&D strategies have to be devised so as to ensure better product quality.

Market players of women healthcare industries are Allergan plc. (Ireland), Amgen (California), Bayer a G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.).Some of the other noteworthy companies Merck & Co., Inc., (U.S.), Pfizer Inc., (U.S.), and Teva Pharmaceuticals (Israel).

Global Women Healthcare Market – Segments

The Women Healthcare Market is segmented on the basis of indications, diagnosis and treatment and also on the basis of end users.

On Basis Of Indications: Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer and Others.

The Gynecologic cancer segment has been further divided into breast, ovarian or other types of cancer.

On The Basis Of Diagnosis: Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing and Others.

On The Basis Of Treatment: Therapeutics, Surgeries and Others.

On The Basis Of End Users: Hospitals & Clinics, Gynecology Centers, Research Institutes, And Others

Global Women Healthcare Market – Regional Analysis

For the purpose of region wise analysis, the market is segmented into North America, Europe, Asia-Pacific and Middle East and Africa. North America was commands the largest market share which is expected to reach USD 21,782.6 million by 2023 due to well-developed economy and initiatives taken to promote women healthcare in the region. On the other hand factors such as high cost of diagnosis and treatments are restricting the market growth in the Middle East & African region, while Asia-Pacific countries are expected to be the fastest growing region with a CAGR of 5.46% from 2017-2023.


GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/3121 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email:  salesteam@marketresearchfuture.com

Leave a Reply

Your email address will not be published. Required fields are marked *